Entering text into the input field will update the search result below

Adhera gets European patent covering MLR-1019

Business woman signs a patent. Intellectual property protection concept. Patent attorney.

Irina Vodneva/iStock via Getty Images

  • Adhera Therapeutics (OTCPK:ATRX) announces that a new European patent has been issued for MLR-1019 (armesocarb), a drug licensed by the company from Melior Discovery.
  • With the latest addition, MLR-1019 has been issued 11 patents (3 in U.S., Europe Union, Australia, Chinese, Eurasia, Israel, Mexico, South

Recommended For You

About ATRX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ATRX--
Adhera Therapeutics, Inc.